MRNA levels in control rat liver display strain-specific, Hereditary, and AHR-dependent components

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Boutros, Paul C ^a,b   Moffat, Ivy D ^a   Okey, Allan B ^a   Pohjanvirta, Raimo ^c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; DNA BINDING PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR;

AHR GENE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS BREEDING; GENE INTERACTION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOME; HERITABILITY; INTER STRAIN VARIABILITY; INTRA STRAIN VARIABILITY; KIDNEY; LIVER; LONG EVANS RAT; MOUSE; NONHUMAN; PATTERN RECOGNITION; PROMOTER REGION; RAT; SPRAGUE DAWLEY RAT; STRAIN DIFFERENCE; TRANSCRIPTION FACTOR BINDING SITE; WISTAR RAT; ANIMAL; BINDING SITE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC DATABASE; GENETICS; INHERITANCE; METABOLISM; SPECIES DIFFERENCE;

MUS; RATTUS; RATTUS NORVEGICUS;

ANIMALS; BINDING SITES; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME; INHERITANCE PATTERNS; LIVER; MICE; RATS; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; SPECIES SPECIFICITY; TRANSCRIPTION FACTORS;

EID: 79960088990     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018337     Document Type: Article

References (58)

1. Amin RP, Hamadeh HK, Bushel PR, Bennett L, Afshari CA, et al. (2002) Genomic interrogation of mechanism(s) underlying cellular responses to toxicants. Toxicology 181-182: 555-563.
2. Burgoon LD, Boutros PC, Dere E, Zacharewski TR, (2006) dbZach: A MIAME-compliant toxicogenomic supportive relational database. Toxicol Sci 90: 558-568.
3. Guo L, Lobenhofer EK, Wang C, Shippy R, Harris SC, et al. (2006) Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol 24: 1162-1169.
4. Jacob HJ, Kwitek AE, (2002) Rat genetics: attaching physiology and pharmacology to the genome. Nat Rev Genet 3: 33-42.
5. Lazar J, Moreno C, Jacob HJ, Kwitek AE, (2005) Impact of genomics on research in the rat. Genome Res 15: 1717-1728.
6. Martin R, Rose D, Yu K, Barros S, (2006) Toxicogenomics strategies for predicting drug toxicity. Pharmacogenomics 7: 1003-1016.
7. Frijters R, Verhoeven S, Alkema W, van Schaik R, Polman J, (2007) Literature-based compound profiling: application to toxicogenomics. Pharmacogenomics 8: 1521-1534.
8. Jin W, Riley RM, Wolfinger RD, White KP, Passador-Gurgel G, et al. (2001) The contributions of sex, genotype and age to transcriptional variance in Drosophila melanogaster. Nat Genet 29: 389-395.
9. Ranz JM, Castillo-Davis CI, Meiklejohn CD, Hartl DL, (2003) Sex-dependent gene expression and evolution of the Drosophila transcriptome. Science 300: 1742-1745.
10. Fernandes C, Paya-Cano JL, Sluyter F, D'Souza U, Plomin R, et al. (2004) Hippocampal gene expression profiling across eight mouse inbred strains: towards understanding the molecular basis for behaviour. Eur J Neurosci 19: 2576-2582.
11. Daniels GM, Buck KJ, (2002) Expression profiling identifies strain-specific changes associated with ethanol withdrawal in mice. Genes Brain Behav 1: 35-45.
12. Cheung VG, Conlin LK, Weber TM, Arcaro M, Jen KY, et al. (2003) Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet 33: 422-425.
13. Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, et al. (2004) Genetic analysis of genome-wide variation in human gene expression. Nature 430: 743-747.
14. Cheung VG, Spielman RS, Ewens KG, Weber TM, Morley M, et al. (2005) Mapping determinants of human gene expression by regional and genome-wide association. Nature 437: 1365-1369.
15. Rockman MV, Kruglyak L, (2006) Genetics of global gene expression. Nat Rev Genet 7: 862-872.
16. Monks SA, Leonardson A, Zhu H, Cundiff P, Pietrusiak P, et al. (2004) Genetic inheritance of gene expression in human cell lines. Am J Hum Genet 75: 1094-1105.
17. Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, et al. (2003) Genetics of gene expression surveyed in maize, mouse and man. Nature 422: 297-302.
18. Seidel SD, Hung SC, Lynn Kan H, Bhaskar Gollapudi B, (2006) Background gene expression in rat kidney: influence of strain, gender, and diet. Toxicol Sci 94: 226-233.
19. Cerutti C, Kurdi M, Bricca G, Hodroj W, Paultre C, et al. (2006) Transcriptional alterations in the left ventricle of three hypertensive rat models. Physiol Genomics 27: 295-308.
20. Boedigheimer MJ, Wolfinger RD, Bass MB, Bushel PR, Chou JW, et al. (2008) Sources of variation in baseline gene expression levels from toxicogenomics study control animals across multiple laboratories. BMC Genomics 9: 285.
21. Pritchard C, Coil D, Hawley S, Hsu L, Nelson PS, (2006) The contributions of normal variation and genetic background to mammalian gene expression. Genome Biol 7: R26.
22. Tuomisto JT, Viluksela M, Pohjanvirta R, Tuomisto J, (1999) The AH receptor and a novel gene determine acute toxic responses to TCDD: segregation of the resistant alleles to different rat lines. Toxicol Appl Pharmacol 155: 71-81.
23. Boutros PC, Okey AB, (2005) Unsupervised pattern recognition: an introduction to the whys and wherefores of clustering microarray data. Brief Bioinform 6: 331-343.
24. Bachtiary B, Boutros PC, Pintilie M, Shi W, Bastianutto C, et al. (2006) Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity. Clin Cancer Res 12: 5632-5640.
25. Smyth GK, (2003) Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments. Stat App Genet Mol Biol 3: 1-26.
26. Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, et al. (2004) Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428: 493-521.
27. Okey AB, Riddick DS, Harper PA, (1994) Molecular biology of the aromatic hydrocarbon (dioxin) receptor. Trends Pharmacol Sci 15: 226-232.
28. McMillan BJ, Bradfield CA, (2007) The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems. Mol Pharmacol 72: 487-498.
29. Okey AB, (2007) An aryl hydrocarbon receptor odyssey to the shores of toxicology: the Deichmann Lecture, International Congress of Toxicology-XI. Toxicol Sci 98: 5-38.
30. Pohjanvirta R, Wong JM, Li W, Harper PA, Tuomisto J, et al. (1998) Point mutation in intron sequence causes altered carboxyl-terminal structure in the aryl hydrocarbon receptor of the most 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant rat strain. Mol Pharmacol 54: 86-93.
31. Moffat ID, Boutros PC, Chen H, Okey AB, Pohjanvirta R, (2010) Aryl hydrocarbon receptor (AHR)-regulated transcriptomic changes in rats sensitive or resistant to major dioxin toxicities. BMC Genomics 11: 263.
32. Boutros PC, Bielefeld KA, Pohjanvirta R, Harper PA, (2009) Dioxin-dependent and dioxin-independent gene batteries: comparison of liver and kidney in AHR-null mice. Toxicol Sci 112: 245-256.
33. Tijet N, Boutros PC, Moffat ID, Okey AB, Tuomisto J, et al. (2006) Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol Pharmacol 69: 140-153.
34. Boutros PC, Yan R, Moffat ID, Pohjanvirta R, Okey AB, (2008) Transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in liver: comparison of rat and mouse. BMC Genomics 9: 419.
35. Boverhof DR, Burgoon LD, Tashiro C, Sharratt B, Chittim B, et al. (2006) Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice. Toxicol Sci 94: 398-416.
36. Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, et al. (2003) GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 4: R28.
37. Pritchard CC, Hsu L, Delrow J, Nelson PS, (2001) Project normal: defining normal variance in mouse gene expression. Proc Natl Acad Sci U S A 98: 13266-13271.
38. Boorman GA, Irwin RD, Vallant MK, Gerken DK, Lobenhofer EK, et al. (2005) Variation in the hepatic gene expression in individual male Fischer rats. Toxicol Pathol 33: 102-110.
39. Boutros PC, Lau SK, Pintilie M, Liu N, Shepherd FA, et al. (2009) Prognostic gene signatures for non-small-cell lung cancer. Proc Natl Acad Sci U S A 106: 2824-2828.
40. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
41. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, et al. (2007) A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 356: 11-20.
42. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, et al. (2006) Global variation in copy number in the human genome. Nature 444: 444-454.
43. Cutler G, Marshall LA, Chin N, Baribault H, Kassner PD, (2007) Significant gene content variation characterizes the genomes of inbred mouse strains. Genome Res 17: 1743-1754.
44. Gu YZ, Hogenesch JB, Bradfield CA, (2000) The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 40: 519-561.
45. Pohjanvirta R, Viluksela M, Tuomisto JT, Unkila M, Karasinska J, et al. (1999) Physicochemical differences in the AH receptors of the most TCDD-susceptible and the most TCDD-resistant rat strains. Toxicol Appl Pharmacol 155: 82-95.
46. Lund AK, Goens MB, Kanagy NL, Walker MK, (2003) Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure. Toxicol Appl Pharmacol 193: 177-187.
47. Woon PY, Kaisaki PJ, Braganca J, Bihoreau MT, Levy JC, et al. (2007) Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes. Proc Natl Acad Sci U S A 104: 14412-14417.
48. Boorman GA, Blackshear PE, Parker JS, Lobenhofer EK, Malarkey DE, et al. (2005) Hepatic gene expression changes throughout the day in the Fischer rat: implications for toxicogenomic experiments. Toxicol Sci 86: 185-193.
49. Pohjanvirta R, Tuomisto J, (1990) Mechanism of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Appl Pharmacol 105: 508-509.
50. Pohjanvirta R, Boutros PC, Moffat ID, Linden J, Wendelin D, et al. (2008) Genome-wide effects of acute progressive feed restriction in liver and white adipose tissue. Toxicol Appl Pharmacol 230: 41-56.
51. Franc MA, Moffat ID, Boutros PC, Tuomisto JT, Tuomisto J, et al. (2008) Patterns of dioxin-altered mRNA expression in livers of dioxin-sensitive versus dioxin-resistant rats. Arch Toxicol 82: 809-830.
52. Gautier L, Cope L, Bolstad BM, Irizarry RA, (2004) affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20: 307-315.
53. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
54. Efron B, Tibshirani R, (2002) Empirical bayes methods and false discovery rates for microarrays. Genet Epidemiol 23: 70-86.
55. Wasserman WW, Sandelin A, (2004) Applied bioinformatics for the identification of regulatory elements. Nat Rev Genet 5: 276-287.
56. Frith MC, Fu Y, Yu L, Chen JF, Hansen U, et al. (2004) Detection of functional DNA motifs via statistical over-representation. Nucleic Acids Res 32: 1372-1381.
57. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B, (2004) JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32 Database issue: D91-94.
58. Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, et al. (2003) The UCSC Genome Browser Database. Nucleic Acids Res 31: 51-54.